Home4516 • TYO
add
Nippon Shinyaku Co Ltd
Previous close
¥5,796.00
Day range
¥5,667.00 - ¥5,841.00
Year range
¥2,967.00 - ¥6,529.00
Market cap
400.57B JPY
Avg Volume
833.03K
P/E ratio
12.02
Dividend yield
2.17%
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 40.10B | -0.25% |
Operating expense | 17.92B | -15.11% |
Net income | 7.50B | 22.85% |
Net profit margin | 18.72 | 23.16% |
Earnings per share | — | — |
EBITDA | 11.14B | 34.11% |
Effective tax rate | 21.19% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.29B | 15.79% |
Total assets | 297.04B | 10.61% |
Total liabilities | 36.83B | 10.62% |
Total equity | 260.21B | — |
Shares outstanding | 67.40M | — |
Price to book | 1.50 | — |
Return on assets | 8.09% | — |
Return on capital | 9.19% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 7.50B | 22.85% |
Cash from operations | 7.14B | -33.41% |
Cash from investing | -165.00M | 97.48% |
Cash from financing | -608.00M | 8.98% |
Net change in cash | 7.01B | 266.27% |
Free cash flow | 5.12B | 292.01% |
About
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
Founded
Oct 1, 1919
Website
Employees
2,243
